Novartis drug pasireotide LAR shows superior efficacy compared to Sandostatin® LAR® in Phase III trial of patients with acromegaly
Results of the largest Phase III study...
7 May 2012 | By Novartis
Results of the largest Phase III study...
List view / Grid view
Results of the largest Phase III study...
7 May 2012 | By Novartis
Results of the largest Phase III study...
A study found that the investigational drug Signifor®, normalized cortisol…
7 March 2012 | By Novartis
A study found that the investigational drug Signifor®, normalized cortisol levels...